Navigation Links
Cephalon Quarterly Conference Call Invitation
Date:3/31/2009

First Quarter 2009 Earnings Conference Call Tuesday, May 5, 2009, 5:00 p.m. U.S. EDT

FRAZER, Pa., March 31 /PRNewswire-FirstCall/ -- Cephalon, Inc. (Nasdaq: CEPH) has scheduled its regular quarterly earnings conference call covering first quarter 2009 results for 5:00 p.m. EDT on Tuesday, May 5, 2009.

May 5, 2009 Schedule

4:10 p.m. EDT -- Q1 2009 results will be distributed by PRNewswire

4:50 p.m. EDT -- To participate in the conference call, dial 913-312-1232 and refer to Conference Code Number 9819274

5:00 p.m. EDT -- Conference call begins promptly.

Simultaneous Webcast

Investors can listen to the call live by logging on to the company's website at www.cephalon.com and clicking on "Investors," then "Webcast." Please click on the link and follow the prompts for registration and access.

If you are unable to listen to the live broadcast, an audio or webcast replay of the call will be available approximately two hours after the event until 8:00 p.m. EDT, May 12, 2009. To listen to the audio replay, dial 719-457-0820 and use the Conference Code Number 9819274.

Additional information presented on the conference call may be made available on the Investors page of the company's website.


'/>"/>
SOURCE Cephalon, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Cephalon Launches Takeover Offer for Australian Biotechnology Company, Arana Therapeutics
2. Cephalon Quarterly Conference Call Invitation
3. Cephalon, Inc. to Present at the J.P. Morgan Healthcare Conference
4. Cephalon and ImmuPharma Sign a $15 million Option Agreement for Late- Stage Experimental Lupus Medication
5. Video: Cephalon Receives FDA Approval for TREANDA to Treat Patients with Relapsed Indolent Non-Hodgkins Lymphoma
6. Cephalon Receives FDA Approval for TREANDA to Treat Patients with Relapsed Indolent Non-Hodgkins Lymphoma
7. Ohio Sales Reps Information Launched Massive Government Investigation of Cephalon
8. Biopharmaceutical Company, Cephalon, To Pay $425 Million & Enter Plea to Resolve Allegations of Off-Label Marketing
9. Cephalon Announces FDA Advisory Committee Recommendation Against Approval of an Expanded Label for FENTORA
10. Cephalon Conference Call Invitation
11. Cephalon Reports Strong First Quarter Earnings
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/25/2017)... ... April 25, 2017 , ... A stressful work environment ... can also decrease overall productivity and performance in the workplace. The goal of Clearview ... the last few weeks of April, Clearview Resolution Services will be shutting down the ...
(Date:4/25/2017)... ... April 25, 2017 , ... A ... student test score performance for the 2015-16 school year across Wisconsin’s public schools, ... Though it highlights important patterns in student test score performance, the report’s limited ...
(Date:4/25/2017)... ... April 25, 2017 , ... Lake Park Dental is ... using Invisalign® in Lutz, FL. With the help of this highly-effective, yet ... with fewer potential complications, more discretion and less pain. , Drs. Sarah Jockin, ...
(Date:4/25/2017)... ... April 25, 2017 , ... As pharmaceutical companies are held ... with process innovation in drug formulation and manufacturing. CoreRx offers its clients ... equipment in support of their development and manufacturing goals. , The company ...
(Date:4/25/2017)... ... , ... Back Pain Centers of America (BPC), which connects people ... their area, announces the launch of a new and proprietary customer relationship management (CRM) ... reputable physicians to help them with back or neck pain and helps to match ...
Breaking Medicine News(10 mins):
(Date:4/24/2017)... April 24, 2017 Solentim, the developer ... the addition of a major new product line ... Seeding,). The VIPS has been developed for automatically ... microplates as part of the process to generate ... simple and more reliable solution when compared to ...
(Date:4/20/2017)... 20, 2017  Vivify Health, the pioneer and market ... awarded a very significant patent for the advancement of ... care via digital health.  This landmark patent provides the ... further secures Vivify,s position as the leader in remote ... the first company to apply consumer mobile devices, wireless ...
(Date:4/20/2017)... MARLBOROUGH, Mass. , April 20, 2017 /PRNewswire/ ... company developing innovative therapeutics that address significant unmet ... new data from the Company,s consumer product development ... technology, at the Society for Investigative Dermatology (SID) ... is to advance and promote the sciences relevant ...
Breaking Medicine Technology: